98%
921
2 minutes
20
The use of teas made from locally cultivated Artemisia annua to fight malaria in remote areas where access to care is difficult is a matter of debate. This study aimed at document differences in the composition of A. annua teas cultivated in Benin to be sold as antimalarial teas, and in France, and their impact on antiplasmodial activity. A. annua teas were prepared with plants from one location in south France and from ten different plantations in Benin. Artemisinin was quantified in herbal teas with a liquid chromatography system coupled to mass spectrometry and multiple reaction monitoring detection methods. The herbal teas were tested against chloroquine-sensitive 3D7 strain of Plasmodium falciparum using isotopic microtest to determine IC50 values and calculate the concentration of artemisinin corresponding to the IC50 of the teas [ART(tea)_IC50]. Chemical profiles were determined by liquid chromatography coupled to high resolution mass spectrometry and a metabolomic analysis was performed to annotate compounds statistically linked to the antiplasmodial properties of the teas. Artemisinin content varied between 0.3 mg/L for tea with plants from France to 15.7 mg/L for teas made with plants from Benin with differences between locations. Artemisinin content was decreasing after a one-year storage of the plant for 3 localities in Benin with loss of 33%, 48% and 24% (P < 0.05). Artemisinin concentrations and antiplasmodial activity of teas were positively correlated although the comparison of ART(tea)_IC50s to IC50 of pure artemisinin suggested that other compounds present in the tea were involved in the activity, either enhancing or limiting it. Unknown alkaloids in A. annua teas correlated to antiplasmodial activity were also detected. These findings suggest that A. annua teas deserve further studies to identify other metabolites of interest and determine their role in antiplasmodial activity in relation to other molecules, particularly artemisinin.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12373170 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0330682 | PLOS |
PLoS One
September 2025
UMR 152 PharmaDev, Université de Toulouse, UPS, IRD, Toulouse, France.
Artemisia annua L. (A. annua) is a medicinal herb that has been used for the last two millennia to treat various diseases.
View Article and Find Full Text PDFPLoS One
August 2025
UMR 152 PharmaDev, Université Paul Sabatier-Toulouse 3, IRD, Université de Toulouse, Toulouse France.
The use of teas made from locally cultivated Artemisia annua to fight malaria in remote areas where access to care is difficult is a matter of debate. This study aimed at document differences in the composition of A. annua teas cultivated in Benin to be sold as antimalarial teas, and in France, and their impact on antiplasmodial activity.
View Article and Find Full Text PDFMalar J
May 2025
Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Background: The recent emergence of artemisinin resistance in Africa is drawing scrutiny toward the use of alternative anti-malarial therapy based on Artemisia annua and Artemisia afra phytotherapies. This study aimed to determine if either A. annua and A.
View Article and Find Full Text PDFMolecules
May 2024
Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, MA 01609, USA.
Fibrosis is a ubiquitous pathology, and prior studies have indicated that various artemisinin (ART) derivatives (including artesunate (AS), artemether (AM), and dihydroartemisinin (DHA)) can reduce fibrosis in vitro and in vivo. The medicinal plant L. is the natural source of ART and is widely used, especially in underdeveloped countries, to treat a variety of diseases including malaria.
View Article and Find Full Text PDFAnn Afr Med
February 2024
Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.